Breast-specific gamma imaging (BSGI) developer Dilon Diagnostics said that new research has found BSGI to be nearly twice as effective in finding breast cancers than ultrasound, and more than three times as likely to lead to a correct diagnosis.
The multicenter study was presented in Washington, DC, at the American Society of Clinical Oncology's (ASCO) Breast Cancer Symposium. Philadelphia breast surgeon Ann Rosenberg, MD, compared the two modalities in patients who had dense breast tissue and a remaining diagnostic concern after mammography.
She also concluded that for patients with dense breasts and an unresolved clinical concern, the benefit of performing BSGI outweighed the radiation risk by a factor of 295:1, the Newport News, VA-based vendor said.
Related Reading
Dilon touts low radiation in BSGI study, October 5, 2010
Dilon reports positive BSGI research, June 30, 2010
Dilon touts BSGI measurement study, May 3, 2010
BSGI proves best at detecting invasive lobular cancer, February 11, 2009
Breast-specific gamma imaging reveals unseen cancers, December 4, 2008
Copyright © 2010 AuntMinnie.com